Emergent BioSolutions to Release Fourth Quarter 2021 Financial Results and Conduct Conference Call on February 24, 2022

Rhea-AI Summary

Emergent BioSolutions (NYSE: EBS) will hold a conference call on February 24, 2022, at 5:00 PM ET to discuss its fourth-quarter 2021 financial results and business developments. The call will provide insights into the financial outlook for 2022, and revenue guidance for Q1 2022. Interested participants can join via telephone or webcast. Further details regarding the conference call are available on the company's website.

GAITHERSBURG, Md., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, February 24, 2022 at 5:00 pm eastern time to discuss the financial results for the fourth quarter 2021, recent business developments, financial outlook for full year 2022, and revenue guidance for the first quarter of 2022.

This conference call can be accessed live by telephone or by webcast:

Teleconference Information:
Dial in number – toll-free: (855) 766-6521
Dial in number – toll: (262) 912-6157
Conference ID: 7619558

Webcast Information:
Visit https://edge.media-server.com/mmc/p/tfd93ojy for the live webcast.

A replay of the call can be accessed from the Investors page of the Emergent website.

About Emergent BioSolutions
At Emergent, our mission is to protect and enhance life. We develop, manufacture, and deliver protections against public health threats through a pipeline of innovative vaccines and therapeutics. For over 20 years, we’ve been at work defending people from things we hope will never happen—so that we’re prepared just in case they ever do. We do what we do because we see the opportunity to create a better, more secure world. One where preparedness empowers protection from the threats we face. And peace of mind prevails. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information, visit our website and follow us on LinkedIn, Twitter, and Instagram.

Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
240-631-3280
burrowsr@ebsi.com  

Media Contact:
Matt Hartwig
Senior Director, Media Relations
mediarelations@ebsi.com

FAQ

What are the financial results for Emergent BioSolutions in Q4 2021?

The financial results for Q4 2021 will be discussed during the conference call on February 24, 2022.

When is the Emergent BioSolutions conference call scheduled?

The conference call is scheduled for February 24, 2022, at 5:00 PM ET.

How can I access the Emergent BioSolutions conference call?

You can access the call via telephone at (855) 766-6521 for toll-free or (262) 912-6157 for toll calls, or through the live webcast on their website.

What guidance will Emergent BioSolutions provide in the conference call?

Emergent BioSolutions will provide revenue guidance for the first quarter of 2022 during the conference call.